Breaking News

Hitachi Opens Cell and Gene Therapy Facility in NJ

NJ Gov. Phil Murphy was on hand for the ribbon cutting ceremony.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hitachi Chemical Advanced Therapeutics Solutions (HCATS), a subsidiary of Hitachi Chemical Co., Ltd. representing Hitachi Chemical’s Regenerative Medicine Business Sector (RMBS) in North America, has opened its new cell and gene therapy manufacturing facility in Allendale, NJ. The new facility is the company’s first to be designed from the ground up to meet the needs of commercial cell and gene therapy products and more than doubles HCATS’ existing manufacturing capacity in New Jersey.   The fac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters